SUCCESSOR-1
Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared to Pomalidomide, Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Arms / Cohorts
Experimental, Stage 1 Arm A1:Mezigdomide (1 mg) + Bortezomib + Dexamethasone
Accepting patients
Experimental, Stage 1 Arm A2:Mezigdomide (0.6 mg) + Bortezomib + Dexamethasone
Accepting patients
Experimental, Stage 1 Arm A3:Mezigdomide (0.3 mg) + Bortezomib + Dexamethasone
Accepting patients
Comparator, Stage 1 Arm B:Pomalidomide + Bortezomib + Dexamethasone
Accepting patients
Experimental, Stage 2 Arm A:Mezigdomide + Bortezomib + Dexamethasone
Not yet accepting
Comparator, Stage 2 Arm B:Pomalidomide + Bortezomib + Dexamethasone
Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.